Low disease activity in rheumatoid arthritis (RA) means the inflammation and symptoms measured during a clinical assessment are at a low level, though they may not be completely gone. Doctors estimate it with a tested scoring tool that can include tender and swollen joints, your assessment of how you feel, the clinician’s assessment, and blood tests. It is a common treatment goal, especially when remission is not achievable.
What Does Low Disease Activity Mean in Everyday Life?
Rheumatoid arthritis is an inflammatory condition that can cause joint pain, swelling, stiffness, and difficulty with daily activities. When disease activity is low, these effects are generally better controlled than when the condition is moderately or highly active. A person may have fewer swollen or tender joints and less stiffness, although some symptoms can remain.
Low disease activity describes how well the inflammation associated with RA is controlled at a particular time. It does not mean the condition has disappeared or that every joint is free from symptoms. The term is based on a clinical assessment rather than simply how a person feels on a given day.
For example, someone may report feeling better and have fewer swollen joints than at an earlier appointment. Their rheumatologist can use a disease activity score to assess whether the improvement meets the accepted range for low disease activity. Repeated assessments help establish whether that level of control is being maintained.
How Do Doctors Measure Low Disease Activity?
There is no single symptom or blood test that defines low disease activity in every person with RA. Healthcare professionals use validated scoring systems that combine several pieces of information. The American College of Rheumatology (ACR) identifies tools such as the Clinical Disease Activity Index (CDAI), Disease Activity Score using 28 joints (DAS28), Simplified Disease Activity Index (SDAI), and Routine Assessment of Patient Index Data 3 (RAPID3) for evaluating rheumatoid arthritis activity.
Depending on the scoring system, the assessment may include:
- Tender and swollen joint counts: The clinician examines specific joints to check for tenderness and swelling.
- Your assessment of your health: You may rate your overall disease activity, pain, or how well you feel.
- The clinician's assessment: The healthcare professional evaluates the overall level of disease activity using the chosen tool.
- Blood tests: Some scores include markers of inflammation, such as C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR).
According to the American College of Rheumatology's recommendations on rheumatoid arthritis disease activity measures, several validated tools can support regular assessment and treatment decisions. The tools do not all use the same information, and some require blood test results while others do not.
What Score Indicates Low Disease Activity in Rheumatoid Arthritis?
The score that indicates low disease activity depends on which measurement tool a healthcare professional uses. Each system has its own scoring range and thresholds, so a result from one tool should not be interpreted using the cutoffs for another.
Two common examples help explain how these scores work:
- DAS28: A score below 3.2 is commonly used as an example of low disease activity.
- CDAI: Scores from 2.9 to 10 indicate low disease activity under the commonly used CDAI categories.
The National Institute for Health and Care Excellence (NICE) identifies a DAS28 score below 3.2 as an example of low disease activity and a score below 2.6 as an example of remission. The Arthritis Foundation's explanation of disease activity measurements describes the corresponding CDAI categories.
These numbers are clinical reference points, not a self-assessment test. A rheumatologist interprets the result alongside the joint examination, symptoms, blood test findings when relevant, medical history, and changes since previous appointments. Using the same measurement method over time can make it easier to track progress and determine whether the treatment goal has been reached.
How Is Low Disease Activity Different From Remission?
Low disease activity and remission are related, but they are not the same. Both describe levels of rheumatoid arthritis activity, with remission representing a more stringent target and low disease activity allowing for some ongoing signs of disease.
In remission, signs and symptoms of active inflammation are absent or very limited according to the criteria being used. Low disease activity means the condition is well controlled but some inflammatory activity or symptoms may remain. Neither term necessarily describes the amount of joint damage that occurred before the current level of control was reached.
The American College of Rheumatology and the European Alliance of Associations for Rheumatology (EULAR) revised their remission criteria for rheumatoid arthritis in 2022. These criteria use defined clinical measures rather than relying on a person's general impression of improvement alone. This distinction helps clinicians assess disease control more consistently.
Remission is often the preferred goal, particularly in early rheumatoid arthritis. However, achieving remission is not possible for everyone. In established disease, or when remission cannot be achieved despite appropriate treatment, low disease activity can be a reasonable treatment target. The most appropriate goal depends on the person's circumstances and risk of further joint damage.
Why Is Low Disease Activity an Important Treatment Goal?
The aim of rheumatoid arthritis treatment is to control inflammation as effectively as possible, maintain physical function, and limit the risk of long-term joint damage. Low disease activity is therefore more than a description of how a person feels; it is a measurable target that can help guide ongoing care.
NICE recommends a treat-to-target approach for adults with active RA. Under this approach, treatment aims for remission or, when remission cannot be achieved, low disease activity. The target may be adjusted according to factors such as the risk of changes visible on X-rays. Reaching a target can require reviewing the treatment plan when the response is not sufficient.
Regular measurement also helps clinicians distinguish between improvement that is sustained and improvement that may be temporary. A lower score can be encouraging, but continued assessment is needed to determine whether disease activity remains controlled and whether the current plan is meeting the agreed treatment goal.
What Happens After Low Disease Activity Is Reached?
Reaching low disease activity is an important milestone, but it is not the end of rheumatoid arthritis care. The next objective is to maintain that level of control. The European Alliance of Associations for Rheumatology (EULAR), in its 2025 recommendations update published in 2026, continues to identify sustained remission or low disease activity as a treatment target for people with RA. Its recommendations also emphasise regular monitoring when the disease is active.
Follow-up appointments allow the healthcare team to review symptoms, examine the joints, assess disease activity scores, and check relevant blood tests when needed. Monitoring can be more frequent while the disease is active or treatment is being adjusted. Once the target is maintained, the schedule may change according to the person's clinical situation and local guidance.
Medication should not be stopped or reduced independently because a score has reached the low-activity range. Even when symptoms improve, the treatment plan may still be needed to maintain control. If disease activity remains low over time, the rheumatologist can discuss whether any treatment adjustment is appropriate, taking account of the risks and benefits.
Can Symptoms Continue When Disease Activity Is Low?
Yes. Some people continue to experience pain, stiffness, fatigue, or difficulty with everyday tasks even when their measured rheumatoid arthritis activity is low. The level of active inflammation is only one part of the overall picture, and symptoms do not always match the disease activity score exactly.
Persistent discomfort may be associated with previous joint damage or other conditions, while ongoing inflammation may still need consideration in some cases. A clinician can review the pattern of symptoms, physical examination findings, test results, and functional changes to understand what might be contributing to the problem. A low score should not be taken to mean that continuing pain or other disruptive symptoms are unimportant.
Contact your healthcare professional if symptoms become persistent, worsen, or interfere with daily activities, or if you notice a change that is difficult to interpret. These changes may warrant reassessment even if a previous appointment showed low disease activity.